Treatment with immune checkpoint inhibitors (ICI), e.g. targeting programmed death ligand 1 (PD-L1) or its receptor programmed cell death protein 1 (PD-1), have improved the therapy of many cancers but failed in PDAC yet. The gene discussed is CD274; the disease is cancer.